Vanadium exposure through lactation produces behavioral alterations and CNS myelin deficit in neonatal rats

Neurotoxicology and Teratology

Volumn 29, Issue 4, 2007, Pages 503-510

  Soazo, Marina ^a   Garcia, Graciela Beatriz ^a  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

Behavior; Myelin; Neurotoxicity; Vanadium

Indexed keywords

VANADIUM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATION; ENVIRONMENTAL EXPOSURE; FEMALE; IMMUNOHISTOCHEMISTRY; LACTATION; LOCOMOTION; MALE; MUSCLE STRENGTH; NEUROTOXICITY; NEWBORN; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; RIGHTING REFLEX;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN; FEMALE; LACTATION; MALE; MOTOR ACTIVITY; MYELIN SHEATH; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; REACTION TIME; REFLEX; TRACE ELEMENTS; VANADIUM;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 34249300142     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2007.03.001     Document Type: Article

References (39)

1. Avila-Costa M.R., Montiel Flores E., Colin-Barenque L., Ordoñez J.L., Gutierrez A.L., Niño-Cabrera H.G., Mussali-Galante P., and Fortoul T.I. Nigrostriatal modifications alter vanadium inhalation: an immunocytochemical and cytological approach. Neurochem. Res. 29 7 (2004) 1365-1369
2. Bendayan M., and Gingras D. Effect of vanadate administration on blood glucose and insulin levels as well as on the exocrine pancreatic function in streptozotocin-diabetic rats. Diabetologia 32 (1989) 561-567
3. Blondel O., Bailbe D., and Portha B. In vivo insulin resistence in steptozotocin-diabetic rats: evidence for reversal following oral vanadate treatment. Diabetologia 32 (1989) 185-190
4. Bosque M.A., Domingo J.L., Llobet J.M., and Corbella J. Variability in the embryotoxicity and fetotoxicity of vanadate with the day of exposure. Vet. Hum. Toxicol. 35 (1993) 1-3
5. Brichard S.M., Okitolondra W., and Henquin J.C. Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats. Endocrinology 123 (1988) 2048-2053
6. Byczkowski J.Z., and Kulkarni A.P. Pro-oxidant biological effects of inorganic component of petroleum: vanadium and oxidative stress (1996). http://www.stormingmedia.us (Report no A647063) www.stormingmedia.us.
7. Carlton B.D., Beneke M.B., and Fisher G.L. Assessment of teratogenicity of ammonium vanadate using Syrian golden hamsters. Environ. Res. 29 (1982) 256-262
8. Davison A.N., and Dobbing J. Applied Neurochemistry (1968), Blackwell, Oxford 253-316
9. Domingo J.L., Paternain J.L., Llobet J.M., and Corbella J. Effects of vanadium on reproduction, gestation, parturition and lactation in rats upon oral administration. Life Sci. 39 (1986) 819-824
10. Domingo J.L. Vanadium: a review of the reproductive and developmental toxicity. Reprod. Toxicol. 10 3 (1996) 175-182
11. Edel J., and Sabbioni E. Vanadium transport across placenta and milk of rats to the fetus and newborn. Biol. Trace Elem. Res. 22 3 (1989) 265-275
12. Eriksson P. Developmental neurotoxicity of environmental agents in the neonate. Neurotoxicology 18 3 (1997) 719-726
13. Garcia G.B., Quiroga A., Strütz N., Martinez A., and Biancardi M.E. Morphological alterations of central nervous system (CNS) myelin in vanadium (V) exposed adult rats. Drug Chem. Toxicol. 27 (2004) 1-13
14. Heyliger C.E., Tahiliani A.G., and Mc Neill J.H. Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 277 (1985) 1474-1477
15. Hope B.K. A global biogeochemical budget for vanadium. Sci. Total. Environ. 141 (1994) 1-10
16. Kolb B., and Whishaw I.Q. Plasticity in the neocortex: mechanisms underlying recovery from early brain damage. Prog. Neurobiol. 32 (1989) 235-276
17. Lazarini C.A., Florio J.C., Lemonica I.P., and Bernardi M.M. Effects of prenatal exposure to deltamethrin on forced swimming behaviour, motor activity and striatal dopamine levels in male and female rats. Neurotoxicol. Teratol. 23 (2001) 665-673
18. Leonard A., and Gerber G.B. Mutagenicity, carcinogenicity and teratogenicity of vanadium compounds. Mutant Res. 317 (1994) 81-88
19. Meyerovitch J., Farfel Z., Sack J., and Shechter Y. Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. J. Biol. Chem. 262 (1987) 6658-6662
20. Miller S.L. Nongenetic animal models of myelin disorders. In: Boulton A.A., Baker G.B., and Butterworth R.F. (Eds). Animal Models of neurological disease vol 1 (1992), Humana Press, Totowa, New Yersey 205-271
21. Mukherjee B., Patra B., Mahapatra S., Banerjee P., Tiwari A., and Chatterjee M. Vanadium - an element of atypical biological significance. Toxicol. Lett. 150 (2004) 135-143
22. Paternain J.L., Domingo J.L., Gomez M., Ortega A., and Corbella J. Developmental toxicity of vanadium in mice after oral administration. J. Appl. Toxicol. 10 (1990) 181-186
23. Poggioli R., Arletti R., Bertolini A., Frigeri C., and Benelli A. Behavioral and developmental outcomes of prenatal and postnatal vanadium exposure in the rat. Pharmacol. Res. 43 4 (2001) 341-347
24. Readhead C., Popko B., Takahashi N., Shine H., Saavedra R., Sidman R., and Hood L. Expression of a myelin basic protein gene in transgenic shiverer mice: correction of the dysmyelinating phenotype. Cell 48 (1987) 703-712
25. Roach A., Boylan K., Horvath S., Prusiner S., and Hood L. Characterization of cloned cDNA representing rat myelin basic protein: absence of expression in brain of shiverer mutant mice. Cell 34 (1983) 799-806
26. Roldan E., and Altamirano M. Chromosomal aberrations, sister chromatid exchanges, cell-cycle kinetics and satellite associations in human lymphocytes cultures exposed to vanadium pentoxide. Mutant Res. 245 (1990) 61-65
27. Rosso S.B., Garcia G.B., Madariaga M.J., Evangelista de Duffard A.M., and Duffard R.O. 2,4-dichlorophenoxyacetic acid in developing rats alters behaviour, myelination and regions brain gangliosides pattern. Neurotoxicology 21 2 (2000) 155-164
28. Rozeik C., and Von Keiserlingk D. The sequence of myelination in the brainstem of the rat monitored by myelin basic protein immunohistochemistry. Dev. Brain Res. 35 (1987) 183-190
29. Sanchez D.J., Ortega A., Domingo J.L., and Corbella J. Developmental toxicity evaluation of orthovanadate in the mouse. Biol. Trace Elem. Res. 30 (1991) 219-226
30. Sanchez D.J., Colomina M.T., and Domingo J.L. Effects of vanadium on activity and learning in rats. Physiol. Behav. 63 3 (1998) 345-350
31. Sanchez D.J., Colomina M.T., Domingo J.L., and Corbella J. Prevention by sodium 4,5-dihydroxybenzene-1,3-disulfonate (Tiron) of vanadium-induced behavioral toxicity in rats. Biol. Trace Elem. Res. 69 (1999) 249-259
32. Schmued L.C. A rapid sensitive histochemical staining for myelin in frozen brain sections. J. Histochem. Cytochem. 38 5 (1990) 717-720
33. Sharma R.P., Coulombe R.A., and Srisuchart B. Effects of dietary vanadium exposure on levels of regional brain neurotransmitters and their metabolites. Biochem. Pharmacol. 35 3 (1986) 461-465
34. Srivastava A.K., and Mehdi M.Z. Insulino-mimetic and anti-diabetic effects of vanadium compounds. Diabet. Med. 22 (2005) 2-13
35. Sternberger L.A., Hardy P.H., Cuculis J.J., and Mayer H.G. The unlabeled antibody enzyme method of immunohistochemistry. Preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J. Histochem. Cytochem. 28 (1970) 315-333
36. Wennig R., and Kirsch N. Vanadium. In: Marcel Dekker (Ed). Handbook on toxicity of inorganic compounds (1988), Seiler-Sigel-Sigel, New York 749-765
37. Wiggins R.C., and Konat G.W. Experimental models of environmental dysmyelination and demyelination in: Developmental Neurotoxicology, Chapter 3 (1994), CRC Press, Inc. 33-41
38. Wiggins R.C. Myelination: a critical stage in development. Neurotoxicology 7 (1986) 103-120
39. Witkowska D., and Brzezinski J. Alteration of brain noradrenaline, dopamine and 5-hydroxytryptamine levels during vanadium poisoning. Pol. J. Pharmacol. Pharm. 31 (1979) 393-398